Internal Server Error

Human Regenerative Technologies - About the company

Human Regenerative Technologies is an unfunded company based in El Segundo (United States), founded in 2016. It operates as an Amniotic and placental allograft leader, advancing regenerative technologies for tissue repair. Human Regenerative Technologies has not raised any funding yet. The company has 165 active competitors, including 24 funded and 31 that have exited. Its top competitors include companies like BioLife Solutions, Integrated DNA Technologies and RoosterBio.

Company Details

Amniotic and placental allograft leader, advancing regenerative technologies for tissue repair. Focused on developing human amniotic and placental properties through scientific understanding and advanced tissue allograft preservation. The company specializes in natural human tissue allografts derived from amniotic membranes and placental connective tissues. They advance tissue preservation technologies derived from the dynamic placental system, which provides the foundation of the body’s various tissues and organs. Their process utilizes sophisticated processing methods to capitalize on the full natural potential of the placenta, preserving function and integrity in their natural hydrated state while allowing for improved handling and delivery methods. They adhere to stringent donor screening, tissue testing, and safety standards. They are accredited by the American Association of Tissue Banks.
Email ID
*****@humantissue.com
Phone Number
+1 **********
Key Metrics
Founded Year
2016
Location
El Segundo, United States
Stage
Unfunded
Ranked
Employee Count
1 as on Jul 31, 2026
Similar Companies
Sign up to download Human Regenerative Technologies' company profile

Human Regenerative Technologies's funding and investors

Human Regenerative Technologies has not raised any funding rounds yet.

Human Regenerative Technologies' founders and board of directors

Founder? Claim Profile

Human Regenerative Technologies' employee count trend

Human Regenerative Technologies has 1 employees as of Jul 26. Here is Human Regenerative Technologies's employee count trend over the years:
Employee count trend for Human Regenerative Technologies
lockUncover Human Regenerative Technologies' growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Human Regenerative Technologies's Competitors and alternates

Top competitors of Human Regenerative Technologies include BioLife Solutions, Integrated DNA Technologies and RoosterBio. Here is the list of Top 10 competitors of Human Regenerative Technologies, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for BioLife Solutions
BioLife Solutions
1987, Bothell (United States), Acquired
Developer of cell and gene therapies with the integrity of a single cell
-
-
67/100
2nd
Logo for Integrated DNA Technologies
Integrated DNA Technologies
1987, Coralville (United States), Acquired
Provider of oligonucleotide-based reagents and kits
-
63/100
3rd
Logo for RoosterBio
RoosterBio
2012, Frederick (United States), Series B
Developer of human mesenchymal stem cells and extracellular vesicles
$38.4M
57/100
4th
Logo for BioLamina
BioLamina
2008, Sundbyberg (Sweden), Series B
Cell culture reagents for stem cell research
$18.2M
56/100
5th
Logo for Shanghai Doning Biotechnology
Shanghai Doning Biotechnology
2005, Shanghai (China), Series C
Provider of cell culture media
$14.9M
53/100
6th
Logo for ArcticZymes
ArcticZymes
2009, Tromso (Norway), Public
Developer of recombinant enzymes from various arctic species
-
49/100
7th
Logo for Toyobo
Toyobo
1882, New York City (United States), Public
Manufacturer of high performance materials including films and functional textiles
-
-
49/100
8th
Logo for Multus
Multus
2019, London (United Kingdom), Series A
Provider of lab-grown meat alternatives
$9.3M
45/100
9th
Logo for Xcell Therapeutics
Xcell Therapeutics
2015, Seoul (South Korea), Public
Provider of serum-free media for cell culture
-
45/100
10th
Logo for Biotangents
Biotangents
2015, Edinburgh (United Kingdom), Series A
Developer of diagnostic assays for infectious diseases in veterinary medicine
$5.62M
45/100
146th
Amniotic and placental allograft leader, advancing regenerative technologies for tissue repair
-
-
22/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Human Regenerative Technologies's competitors? Click here to see the top ones

Human Regenerative Technologies's Investments and acquisitions

Human Regenerative Technologies has made no investments or acquisitions yet.

Reports related to Human Regenerative Technologies

Here is the latest report on Human Regenerative Technologies's sector:

FAQs about Human Regenerative Technologies

Explore our recently published companies
  • Moov - Unfunded company
  • Repairtech - India based, Unfunded company
  • UP! - Leiden based, 2007 founded, Unfunded company
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford